| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/20/2006 | US20060159669 Novel uses of PPAR modulators and professional APCs manipulated by the same |
| 07/20/2006 | US20060159662 Therapeutic anti-melanoma compounds |
| 07/20/2006 | US20060159638 O/W emulsions comprising micronized biologically active agents |
| 07/20/2006 | US20060159626 Method for administering a cytokine to the central nervous system and the lymphatic system |
| 07/20/2006 | CA2595126A1 Methods and compositions for preventing and treating a disease related to glycan dysregulation |
| 07/20/2006 | CA2593777A1 Anti-.alpha.9 integrin antibody and the use thereof |
| 07/19/2006 | EP1681355A1 Sequence-specific DNA recombination in eukaryotic cells |
| 07/19/2006 | EP1681348A1 MU-1 member of the cytokine receptor family |
| 07/19/2006 | EP1681305A2 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 07/19/2006 | EP1681292A1 3-Amino-6-aryl(or 6-heteroaryl)-thieno¬2,3-b|pyridin-2-carboxylic acid amides, pharmaceutical compositions comprising the said and their use as inhibitors of TNFalpha release |
| 07/19/2006 | EP1681064A1 Induction of antigen-specific T cells by interferon |
| 07/19/2006 | EP1680963A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses |
| 07/19/2006 | EP1680429A1 Thieno-pyridinone derivatives as kinase inhibitors |
| 07/19/2006 | EP1680413A1 New rar$g(b) receptor-activating ligand, method for the preparation thereof and use thereof in human medicine and in cosmetics |
| 07/19/2006 | EP1679977A1 Method for modifying the composition of milk and use of milk |
| 07/19/2006 | EP1532124B1 Use of nitrile derivatives as medicament. |
| 07/19/2006 | EP1442058B1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/19/2006 | EP1395575B1 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 07/19/2006 | EP1379695B1 New polynucleotides and polypeptides of the ifnalpha-21 gene |
| 07/19/2006 | EP1370556B1 Metalloproteinase inhibitors |
| 07/19/2006 | EP1301507B1 Mannich base prodrugs of 3 - (pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases |
| 07/19/2006 | EP1299361B1 Pyrazole derivatives |
| 07/19/2006 | EP1294721B1 Cyclic gmp-specific phosphodiesterase inhibitors |
| 07/19/2006 | EP1283725B1 Solid dispersion system of pranlukast with improved dissolution, and the preparing method thereof |
| 07/19/2006 | EP1268453B1 Estrogen agonist/antagonist metabolites |
| 07/19/2006 | EP1220684B1 Methods related to immunostimulatory nucleic acid-induced interferon |
| 07/19/2006 | EP1076566B1 Attenuated mutants of salmonella which constitutively express the vi antigen |
| 07/19/2006 | EP1075492B1 Melanocortin 1 receptor selective compounds |
| 07/19/2006 | CN1805948A Stabilized derivatives of ascorbic acid. |
| 07/19/2006 | CN1805758A Nucleotide and cellular vaccine composition |
| 07/19/2006 | CN1805756A Vav inhibition in graft rejection. |
| 07/19/2006 | CN1805749A New pharmaceutical uses of staurosporine derivatives |
| 07/19/2006 | CN1803797A Inhibitors of dipeptidyl peptidase IV |
| 07/19/2006 | CN1803795A Substituted piperidine compounds for use as h3 histamine receptor antagonists |
| 07/19/2006 | CN1803190A Immune and antiallergic oral product containing IgY and potassium salt, strontium salt added composition, and its preparation method |
| 07/19/2006 | CN1803165A Burdock microecological formulation |
| 07/19/2006 | CN1803162A Rhinological disease-treating pharmaceutical compositions and its preparing method |
| 07/19/2006 | CN1803149A Traditional Chinese medicine deer blood crystal and its preparation method |
| 07/19/2006 | CN1803015A Preparation method of health food with immune regulation and anti-fatigue function |
| 07/19/2006 | CN1802968A Chinese medicinal healthcare tea and its preparation method |
| 07/19/2006 | CN1264856C Inhibitor and stimulator of stem cell proliferation and uses thereof |
| 07/19/2006 | CN1264843C Pyrazolopgrimidinone derivatives having PED 7 inhibitory activity |
| 07/19/2006 | CN1264840C 8-methoxy-(1,2,4) triazolo (1,5-A) pyridine derivatives and their use as adenosine receptor ligands |
| 07/19/2006 | CN1264839C Non-nucleoside reverse transcriptase inhibitors |
| 07/19/2006 | CN1264833C Nonviscous protein type synthetic compound or its carrier combined compound |
| 07/19/2006 | CN1264828C Nitric ester and nitrate salts of specific drugs |
| 07/19/2006 | CN1264532C Compound Chinese herbal medicinal for intensifying immunity |
| 07/19/2006 | CN1264521C Nano selenium of chitin and its preparation method |
| 07/19/2006 | CN1264511C Preparation and use of extracting protopine from plant |
| 07/19/2006 | CN1264494C Method for preparing musk freeze-dried powder injection |
| 07/18/2006 | USRE39197 diaryl sulfides, substituted with cinnamides, such as (2,4-Dichlorophenyl)[2-(E-((6-hydroxyhexylamino)carbonyl)ethenyl)phenyl]sulfide, used for treating inflammatory and immune diseases in mammals |
| 07/18/2006 | US7078566 Organic acid salts for treating tumor diseases, autoimmune diseases, cardiovascular diseases, infections, and viral diseases; nonsettling by inorganic phosphates, nontoxic to tissue, inhibition of sphingomyelinase |
| 07/18/2006 | US7078529 Imidazole derivatives |
| 07/18/2006 | US7078523 Viricides; anticancer agents; immunology moderators |
| 07/18/2006 | US7078506 Canineil-4nucleic acid molecules and uses thereof |
| 07/18/2006 | US7078423 Nitrogen compounds used as xanthine oxidase inhibitors, for prophylaxis of inflammation, reperfusion injuries, gout or inflammatory bowel disorders |
| 07/18/2006 | US7078420 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 07/18/2006 | US7078414 Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions comprising them |
| 07/18/2006 | US7078405 Psychological disorders; anxiolytic agents; dietetics; autoimmune diseases; antidepressants |
| 07/18/2006 | US7078402 Sulfur compounds such as S-methyl 4-dimethylamino-4-methyl-2-pentynethioate, used for prophylaxis of cancers, skin disorders or vision defects |
| 07/18/2006 | US7078376 blood disorders; analgesics; nausea; cardiovascular disorders; anticancer agents; hypotensive agents; headaches; edema; diarrhea; thrombosis; reducing dosage |
| 07/18/2006 | US7078230 Adipose tissue-derived stromal cell that expresses characteristics of a neuronal cell |
| 07/18/2006 | US7078217 Aggrecanase molecules |
| 07/18/2006 | US7078196 Genetic engineering ; induction post-transcriptional gene blocking |
| 07/18/2006 | US7078186 Nucleotide sequences coding polypeptide for use in the prevention, diagnosis and treatment of tumor disorders |
| 07/18/2006 | US7078173 Assays and therapies for latent viral infection |
| 07/18/2006 | US7078054 The capsule shell contains a migrateable component (other than glycerol) which is also present in the capsule filling. |
| 07/18/2006 | US7078020 Heating antipsychotic drug to vaporize; cooling to form condensation aerosol; kit for dispensing thin coating |
| 07/18/2006 | US7078019 Heating a drug ester to vaporize; cooling to form condensation aerosol; drug delivery kit for dispensing thin coatings |
| 07/18/2006 | US7078018 Aerosol therapy; heating, vaporization, cooling, condensation; analgesics; alcoholism |
| 07/18/2006 | US7078017 Delivery of sedative-hypnotics through an inhalation route |
| 07/18/2006 | CA2356320C Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 07/18/2006 | CA2224528C Stilbene compositions in the adamantyl group, compositions containing them and uses |
| 07/18/2006 | CA2148006C Use of non-steroidal antiestrogens for autoimmune diseases |
| 07/13/2006 | WO2006073311A2 Treatment of ibd |
| 07/13/2006 | WO2006073167A1 Pyrrolidine derivatives |
| 07/13/2006 | WO2006073145A1 Method of producing lactic acid bacterium having antiallergic effect |
| 07/13/2006 | WO2006073126A1 Preventive and remedy for dry eye associated with chronic graft versus host disease |
| 07/13/2006 | WO2006073052A1 Novel angiogensis inhibitor |
| 07/13/2006 | WO2006072957A1 Anti-arrythmic drugs and cholesterol absorption inhibitors as neuroprotective agents for the treatment of neurodegenerative and autoimmune disorders |
| 07/13/2006 | WO2006072626A1 Kir-binding agents and methods of use thereof |
| 07/13/2006 | WO2006072600A1 Androstane 17-alpha-carbonate for use in the treatment of inflammatory and allergic conditions |
| 07/13/2006 | WO2006072599A2 Androstane 17-alpha carbonate derivatives for use in the treatment of allergic and inflammatory conditions |
| 07/13/2006 | WO2006072564A1 Antibodies against il-13 receptor alpha 1 and uses thereof |
| 07/13/2006 | WO2006072202A1 A rantes-dt390 recombinant immunotoxin plasmid targeting activated th1 cells and production method and uses thereof |
| 07/13/2006 | WO2006057902A3 2alpha-methyl-19-nor-1alpha-hydroxy-homopregnacalciferol and its uses |
| 07/13/2006 | WO2006057901A3 2-METHYLENE-19-NOR-1α-HYDROXY-17-ENE-HOMOPREGNACALCIFEROL AND ITS USES |
| 07/13/2006 | WO2006050949A3 Superagonistic anti-cd28 antibody |
| 07/13/2006 | WO2006043149A3 Novel dicarboxylic acid derivatives |
| 07/13/2006 | WO2006021457A3 Pyrimidine derivatives |
| 07/13/2006 | US20060155116 Hypoallergenic variants of the parietaria judaica major allergens, uses thereof and compostitions comprising them |
| 07/13/2006 | US20060154977 Therapeutic molecules and methods-1 |
| 07/13/2006 | US20060154952 Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation-and ummunologically-mediated diseases |
| 07/13/2006 | US20060154896 Phosphorylated dextrans |
| 07/13/2006 | US20060154871 Peptides |
| 07/13/2006 | US20060153880 Administering a polynucleotide encoding a Mycrobacterium kansasii-derived alpha antigen; asthma, atopic dermatitis, allergic rhinitis, allergic conjunctivitis |
| 07/13/2006 | US20060153863 Use of inactive immunosuppressive and/or angiogenic immunogenic proteins, for producing secretory IgA's |
| 07/13/2006 | US20060153862 Use of immunogenic immunosuppressive and/or angiogenic proteins which have been rendered inactive, process for their preparation and pharmaceutical or vaccinal uses |
| 07/13/2006 | US20060153849 Methods of treatment with an antibody that suppresses growth differentiation factor-14 activity |
| 07/13/2006 | US20060153845 Method for correcting immune respones and medical agent |